Alec Pollard, PhD
Founder and Director, Saint Louis Behavioral Medicine Institute Anxiety Disorders Center
Professor, Community and Family Medicine at Saint Louis University
Dr. Pollard gives advice to family members who live with someone who refuses treatment for OCD and anxiety disorders Dr. Pollard gives advice to family members who live with someone who refuses treatment for OCD and anxiety disorders and explains a strategy that teaches family members to shape treatment-seeking behavior in someone with an anxiety disorder.
Help us spread the word about the benefits of treatment for anxiety and mood disorders, OCD, and PTSD — for children and teens, women, college students, military and military families.
Please tweet, post on Facebook, or add the links to your own website — whatever works to get the word out that you are not alone and help is here!
Dr. Ailsa Russell describes effective treatments for people with OCD and autism spectrum disorders.
Ailsa Russell, PhD
Clinical Director for the Doctorate in Clinical Psychology
University of Bath
Dr. Russell addresses treatment approaches for people with OCD and autism spectrum disorders. Her research with colleagues at Kings College London has focused on studies of people with autism, in particular trying to adapt or develop effective psychological interventions for anxiety, OCD, and other emotional disorders.
Bradley C. Riemann, PhD (Clinical Director, OCD Center & CBT Services at Rogers Memorial Hospital) and Thröstur Björgvinsson, PhD (Program Director, Houston OCD Program) answered our questions.
Dr. Peggy Richter describes how CBT and various medication options can help treat people with OCD. Listen here.
Peggy Richter, MD
Dr. Richter describes how CBT and various medication options can help treat people with OCD.
Researchers are currently evaluating the Live OCD Free app in an online clinical trial.
Eligible participants will receive free access to the mobile app and will be asked to complete four online surveys over the course of 12 weeks.
The aim of the TOPS Study is evaluate the discontinuation of long-term serotonin reuptake inhibitors (SRIs) in individuals with obsessive-compulsive disorder (OCD).
Participation in TOPS involves an initial screening appointment to ensure eligibility that includes completion of interviews and questionnaires.
Eligible individuals are then randomly assigned to one of two 22-week programs using different techniques to help people come off medication.
All study participants will receive
Adults with OCD who wish to stop taking long-term (2 years or more) SRI medication may be eligible to participate.